Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Epinephrine prices in Germany, the highest-cost reporting region, rose 6.0% in H1 2026, climbing from USD 1,059/KG in Q1 to USD 1,123/KG by Q2 as firmer catecholamine synthesis intermediate costs from Middle East supply disruptions and recovering anaphylaxis auto-injector, emergency medicine, and cardiac resuscitation procurement reversed the brief Q4 2025 market softening. Globally, the average rose from USD 741.6/KG in Q1 to USD 786.1/KG in Q2, a 6.0% gain. For H2 2026, a global average of USD 793-876/KG is expected, with continued firming on growing anaphylaxis auto-injector, emergency medicine, and cardiac arrest resuscitation sector demand globally.
Epinephrine, also known as adrenaline, is a catecholamine hormone produced pharmaceutically by multi-step synthesis from catechol through acetylation, condensation with chloroacetyl chloride, reductive amination with methylamine, and optical resolution to yield the pharmacologically active L-stereoisomer, or alternatively by enzymatic biotransformation routes using tyrosine hydroxylase and aromatic amino acid decarboxylase enzyme systems. The compound acts as a potent full agonist at alpha-1, alpha-2, beta-1, and beta-2 adrenergic receptors, producing bronchodilation, positive cardiac inotropy and chronotropy, peripheral vasoconstriction, and metabolic effects that collectively reverse the life-threatening cardiovascular and respiratory manifestations of systemic anaphylaxis. The largest pull comes from prefilled auto-injector devices for emergency anaphylaxis self-treatment, driven by rising food allergy, insect venom, and drug hypersensitivity prevalence in paediatric and adult populations. Intravenous infusion for cardiac arrest resuscitation adds significant emergency medicine demand. Subcutaneous and nebulised formulations for acute severe asthma, local anaesthetic vasoconstriction adjunct, and ophthalmic preparations add further volumes. Catecholamine synthesis intermediate costs, anaphylaxis auto-injector device procurement cycles, and regional API production capacity all feed into the price.
The balance of supply and demand for epinephrine through H2 2026 leans moderately firm. Catecholamine synthesis intermediate costs firmed from Middle East and aromatic chemical supply disruptions. Anaphylaxis auto-injector global demand is growing with rising food allergy prevalence, expanding prescribing guidelines, and increasing public access defibrillator and emergency kit stocking programmes.
The main upside risk is catecholamine synthesis cost increases alongside accelerating auto-injector global access programme expansion. The main downside risk is supply chain rationalisation and Chinese and Indian API generic entry maintaining price pressure below forecast.
| Region | Price Forecast (USD/KG) | Key Driver |
| Global Average | 793 - 876 | Synthesis cost firming and auto-injector/emergency demand support |
| United States | 850 - 933 | Steady auto-injector and cardiac resuscitation demand holds firm |
| China | 593 - 676 | Domestic API capacity keeps it the most affordable |
| Germany | 1,133 - 1,216 | High synthesis and energy costs keep it the most expensive |
| India | 817 - 900 | Growing auto-injector and export demand holds a firm middle |
US Epinephrine prices averaged USD 911/KG in Q2 2026, up 6.1% from USD 859/KG in Q1 2026. Firmer catecholamine synthesis intermediate costs and recovering anaphylaxis auto-injector and cardiac resuscitation procurement drove consistent buying through the quarter.
Why did the price of Epinephrine change in Q2 2026 in the United States?
Firmer catecholamine synthesis intermediate costs raised the API production floor. Anaphylaxis auto-injector device and cardiac arrest resuscitation drug procurement lifted buying. Asthma bronchodilator, local anaesthetic adjunct, and ophthalmic formulation demand provided additional support near USD 911/KG.
Chinese Epinephrine prices averaged USD 628/KG in Q2 2026, up 6.1% from USD 592/KG in Q1 2026, the lowest among the tracked markets. Spring emergency medicine and auto-injector export and domestic procurement lifted buying. Firmer domestic synthesis costs raised the floor despite domestic API capacity.
Why did the price of Epinephrine change in Q2 2026 in China?
Spring emergency medicine and anaphylaxis auto-injector export and domestic procurement lifted buying. Firmer domestic catecholamine synthesis intermediate costs raised the production floor. Domestic API capacity kept China the most affordable source.
German Epinephrine prices averaged USD 1,123/KG in Q2 2026, up 6.0% from USD 1,059/KG in Q1 2026, the highest among the tracked markets. Higher catecholamine synthesis intermediate and energy costs elevated European API production economics. Consistent anaphylaxis auto-injector, cardiac resuscitation, and emergency medicine demand maintained buying.
Why did the price of Epinephrine change in Q2 2026 in Germany?
Higher catecholamine synthesis intermediate and energy costs elevated European epinephrine API production economics. Middle East supply disruptions added cost premiums to aromatic synthesis substrate chains. Consistent anaphylaxis auto-injector and cardiac resuscitation drug procurement maintained buying near USD 1,123/KG.
Indian Epinephrine prices averaged USD 855/KG in Q2 2026, up 6.1% from USD 806/KG in Q1 2026. Growing anaphylaxis auto-injector export and emergency medicine domestic demand supported buying. Firmer synthesis import costs raised the production floor.
Why did the price of Epinephrine change in Q2 2026 in India?
Growing anaphylaxis auto-injector export and cardiac resuscitation domestic procurement lifted buying. Firmer catecholamine synthesis import costs raised the production floor. Emergency medicine programme export demand provided additional support near USD 855/KG.
US Epinephrine prices averaged USD 859/KG in Q1 2026, recovering about 2.0% from Q4 2025. Recovering anaphylaxis auto-injector and cardiac resuscitation demand and firming synthesis costs held the market near USD 859/KG.
Why did the price of Epinephrine change in Q1 2026 in the United States?
Recovering anaphylaxis auto-injector and cardiac resuscitation procurement maintained buying. Firming catecholamine synthesis intermediate costs raised the production floor. The market recovered to USD 859/KG from the Q4 2025 correction.
Chinese prices averaged USD 592/KG in Q1 2026, recovering about 2.1% from Q4 2025. Post-Lunar New Year emergency medicine and auto-injector restocking and firming costs held the market near USD 592/KG.
Why did the price of Epinephrine change in Q1 2026 in China?
Post-Lunar New Year emergency medicine and auto-injector restocking lifted buying. Firming domestic catecholamine synthesis costs raised the production floor. The market recovered to USD 592/KG from the Q4 2025 correction.
German prices averaged USD 1,059/KG in Q1 2026, recovering about 2.0% from Q4 2025. Recovering anaphylaxis auto-injector and emergency medicine demand and firming synthesis and energy costs held the market near USD 1,059/KG.
Why did the price of Epinephrine change in Q1 2026 in Germany?
Recovering anaphylaxis and cardiac resuscitation procurement maintained buying. Firming synthesis intermediate and energy costs held the production floor. The market recovered to USD 1,059/KG from the Q4 2025 correction.
Indian prices averaged USD 806/KG in Q1 2026, recovering about 2.0% from Q4 2025. Growing emergency medicine and auto-injector export and domestic demand and firming import costs held the market near USD 806/KG.
Why did the price of Epinephrine change in Q1 2026 in India?
Growing anaphylaxis auto-injector and emergency medicine export and domestic procurement maintained buying. Firming synthesis import costs raised the production floor. The market recovered to USD 806/KG from the Q4 2025 correction.
Global Epinephrine prices rose in Q3 2025 on the anaphylaxis and emergency medicine procurement season, dipped in Q4 2025 on synthesis cost moderation, then recovered through Q1 and Q2 2026. The average rose from USD 720.0/KG in Q2 2025 to USD 734.4/KG in Q3, eased to USD 727.1/KG in Q4, then firmed to USD 741.6/KG in Q1 2026 and USD 786.1/KG in Q2 2026, a net gain of about 9.2% over the window. Catecholamine synthesis intermediate cost cycles and anaphylaxis auto-injector and emergency medicine procurement drove the pattern.
| Quarter | Price (USD/KG) | QoQ Change | Direction |
| Q2 2026 | 786.1 | +6.0% | ↑ Rising |
| Q1 2026 | 741.6 | +2.0% | ↑ Rising |
| Q4 2025 | 727.1 | -1.0% | ↓ Falling |
| Q3 2025 | 734.4 | +2.0% | ↑ Rising |
| Q2 2025 | 720.0 | - | - Stable |
| Q3 2026 | In Progress | - | - In Progress |
Epinephrine prices firmed modestly through 2025 on consistent anaphylaxis auto-injector and emergency medicine demand. The global average opened near USD 716/KG in Q1 2025 and closed at USD 727.1/KG in Q4, a full-year gain of about 1.5%. Catecholamine synthesis cost dynamics and anaphylaxis auto-injector procurement drove the quarterly pattern throughout the year.
US prices firmed from about USD 832/KG in Q1 2025 to USD 842/KG by Q4, a gain of 1.2%. Consistent anaphylaxis auto-injector and cardiac resuscitation demand maintained the modest upward trend.
Chinese prices firmed from roughly USD 574/KG in Q1 2025 to USD 580/KG by Q4, a gain of 1.0%. Growing auto-injector export and domestic emergency medicine demand drove modest firming.
German prices firmed from about USD 1,024/KG in Q1 2025 to USD 1,038/KG by Q4, a gain of 1.4%. Consistent anaphylaxis, cardiac resuscitation, and emergency medicine demand and firm synthesis costs supported the market throughout the year.
Indian prices firmed from roughly USD 782/KG in Q1 2025 to USD 790/KG by Q4, a gain of 1.0%. Growing auto-injector export and domestic emergency medicine demand drove modest firming.
Expert Market Research: Your Source for Real-Time Epinephrine Price Intelligence
Expert Market Research tracks Epinephrine prices continuously across every major producing and consuming region. The team traces causation through catecholamine synthesis intermediate economics, anaphylaxis auto-injector and emergency medicine procurement cycles, and regional API production capacity. Contact Expert Market Research today for Epinephrine pricing data, bespoke market analysis, and strategic procurement advisory.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Prefilled auto-injector devices for emergency anaphylaxis self-treatment takes the largest share, driven by rising food allergy and drug hypersensitivity prevalence globally. Intravenous cardiac arrest resuscitation per advanced cardiac life support protocols, subcutaneous and nebulised formulations for acute asthma and croup, local anaesthetic vasoconstriction adjunct, and ophthalmic glaucoma preparations also consume significant volumes globally.
The Q2 2026 average was USD 911/KG in the United States, USD 628/KG in China, USD 1,123/KG in Germany, and USD 855/KG in India. Germany remains the highest-priced market.
The global average rose from USD 741.6/KG in Q1 to about USD 786.1/KG in Q2, a gain of around 6.0%. Recovering anaphylaxis auto-injector and emergency medicine demand and firmer catecholamine synthesis costs drove the H1 firming from the Q4 2025 correction.
Catecholamine synthesis intermediate cost moderation eased the API production floor. Seasonal anaphylaxis auto-injector device and emergency medicine procurement moderation reduced urgency before the H1 2026 recovery.
The global average is expected in the USD 793 to 876/KG range for H2 2026, with continued firming as synthesis costs stay elevated and anaphylaxis auto-injector and emergency medicine sector demand grows.
Germany sits highest on synthesis and energy costs, the United States and India hold a firm middle on auto-injector and emergency demand, and China prices lowest on domestic API production capacity.
This report is updated monthly. For real-time pricing intelligence, contact the Expert Market Research team directly.
Prices respond mainly to catecholamine synthesis intermediate costs, anaphylaxis auto-injector device procurement cycles, and global allergy prevalence trends. Aromatic synthesis substrate prices and auto-injector regulatory approval data are key upstream signals.
China and India hold the largest epinephrine API production capacity. Any catecholamine synthesis intermediate cost shift ripples across markets within one to two quarters.
Buyers can use quarterly trends and forecasts to time auto-injector device and emergency medicine formulation contracts around synthesis cost cycles, build cover when intermediate signals tighten, and monitor allergy prevalence trends and regulatory approval pipelines as primary demand signals.
One Year Subscription
One Year Subscription
USD 799
USD 699
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.